Population Assessment of Tobacco and Health Study (PATH)
The PATH Study is a nationally representative, longitudinal cohort study of adults and youth. The study follows three cohorts. The Wave 1 Cohort participants were selected using a probability sample (conducted September 12, 2013, to December 14, 2014) when they were ages 9 and older. The Wave 4 Cohort participants were selected using a probability replenishment sample (conducted December 1, 2016, to January 3, 2018) when they were ages 10 and older, combined with Wave 1 Cohort members. The Wave 7 Cohort participants were selected using a probability replenishment sample (conducted January 6, 2022, to April 2, 2023) when they were ages 9 and older, combined with members of the Wave 4 Cohort.
Study design
Cohort
Number of participants at first data collection
53,178 (wave 1 cohort participants)
46,169 (wave 7 cohort participants)
52,731 (wave 4 cohort participants)
Age at first data collection
≥ 9 years (participants)
Participant year of birth
Varied (participants)
Participant sex
All
Representative sample at baseline?
Civilian household population ages 9 and older in the United States.
Sample features
Country
Year of first data collection
2013
Primary Institutions
Food and Drug Administration (FDA)
National Institutes of Health (NIH)
Westat
Profile paper DOI
Funders
Food and Drug Administration (FDA)
National Institute on Drug Abuse (NIDA)
National Institutes of Health (NIH)
Ongoing?
Yes
Data types collected
- Interview – face-to-face
- Interview – online
- Interview – phone
- Physical or biological assessment (e.g. blood, saliva, gait, grip strength, anthropometry)
- Secondary data
- Self-report questionnaire – paper or computer assisted
- None
- None
- Existing research data
Engagement
Keywords
